Satsuma Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Satsuma Pharmaceuticals

11/05/2021 23:33

* Satsuma Pharmaceuticals Inc  STSA.OQ  reported a quarterly
adjusted loss of 48 cents​​ per share for the quarter ended
in March. The mean expectation of three analysts for the quarter
was for a loss of 42 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Satsuma Pharmaceuticals Inc's reported EPS for the quarter was
a loss of 48 cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Satsuma Pharmaceuticals Inc shares had fallen by 18.8% this
quarter and gained 4.1% so far this year.
* The company reported a quarterly loss of $10.46 million.
* Wall Street's median 12-month price target for Satsuma
Pharmaceuticals Inc is $7.00 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 11 at 10:33 p.m. GMT.
​All figures in US dollars